LGD-2226 Reference

Plain English

What it is

LGD-2226 is a SARM, which is a lab-made drug that targets the body's muscle-building hormone signals. A drug company created it as an experimental compound, and today it is sold only as a research chemical, not as an approved medicine.

What people use it for

In the bodybuilding and physique community, SARMs are talked about for building muscle and losing fat, but none of that is an approved medical use. For LGD-2226 in particular, real-world use is essentially nonexistent and the online chatter about it is mostly guesswork.

What the science shows

The research on LGD-2226 is preclinical only, meaning it was tested in lab cells and in rodents, mostly for effects on muscle and bone. It never entered a human clinical program, so its safety and effects in people are unknown.

The catch

The FDA warns that SARMs are not approved, are often sold illegally, and global anti-doping rules ban them in sport as anabolic agents (category S1.2) at all times. SARMs as a class are linked to lowered natural testosterone, liver strain, and harmful changes to cholesterol and heart health, and LGD-2226 itself has never been checked for these risks in people.

Reference summary

Preclinical-only literature, primarily rodent body-composition and bone-density models.

Regulatory and posture

Categories

SARM

Aliases

Non-steroidal SARM, Ligand Pharmaceuticals investigational

Evidence posture

preclinical - FDA enforcement attention. Sold only as a research chemical, not for human consumption per legal seller terms. WADA-prohibited under category S1.2 at all times. Preclinical-only literature; no human clinical program.

Regulatory status

No FDA-approved LGD-2226 drug label. WADA prohibits SARMs under category S1.2 at all times. FDA enforcement against SARMs sellers applies.

Content review status

research reference